Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.

Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME.

Arch Gen Psychiatry. 1996 Feb;53(2):109-13.

PMID:
8629886
2.

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.

Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Alazraki A, Selin CE, Ferng HK, Munford P, et al.

Arch Gen Psychiatry. 1992 Sep;49(9):681-9.

PMID:
1514872
3.

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.

Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE.

Arch Gen Psychiatry. 1987 Mar;44(3):211-8. Erratum in: Arch Gen Psychiatry 1987 Sep;44(9):800.

PMID:
3493749
4.

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.

Benkelfat C, Nordahl TE, Semple WE, King AC, Murphy DL, Cohen RM.

Arch Gen Psychiatry. 1990 Sep;47(9):840-8.

PMID:
2393342
5.

The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study.

Hansen ES, Hasselbalch S, Law I, Bolwig TG.

Int J Neuropsychopharmacol. 2002 Mar;5(1):1-10.

PMID:
12057027
6.

Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.

Baxter LR Jr, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, Fairbanks L.

Am J Psychiatry. 1988 Dec;145(12):1560-3.

PMID:
3264118
7.

Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.

Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr.

Am J Psychiatry. 2003 Mar;160(3):522-32.

PMID:
12611834
8.

Positron emission tomography studies of cerebral glucose metabolism in obsessive compulsive disorder.

Baxter LR Jr.

J Clin Psychiatry. 1994 Oct;55 Suppl:54-9. Review.

PMID:
7961533
9.

Changes in metabolism of cerebral glucose after stereotactic leukotomy for refractory obsessive-compulsive disorder: a case report.

Biver F, Goldman S, François A, De La Porte C, Luxen A, Gribomont B, Lotstra F.

J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):502-5.

10.

Cerebral glucose metabolism in obsessive-compulsive hoarding.

Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E, Baker SK, Baxter LR Jr.

Am J Psychiatry. 2004 Jun;161(6):1038-48.

PMID:
15169692
11.

Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: an FDG PET study.

Zuo C, Ma Y, Sun B, Peng S, Zhang H, Eidelberg D, Guan Y.

J Cereb Blood Flow Metab. 2013 Jun;33(6):880-7. doi: 10.1038/jcbfm.2013.23. Epub 2013 Feb 27.

12.

Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.

Apostolova I, Block S, Buchert R, Osen B, Conradi M, Tabrizian S, Gensichen S, Schröder-Hartwig K, Fricke S, Rufer M, Weiss A, Hand I, Clausen M, Obrocki J.

Psychiatry Res. 2010 Nov 30;184(2):105-16. doi: 10.1016/j.pscychresns.2010.08.012. Epub 2010 Oct 14.

PMID:
20947317
13.

Cerebral metabolic pattern in obsessive-compulsive disorder: altered intercorrelations between regional rates of glucose utilization.

Horwitz B, Swedo SE, Grady CL, Pietrini P, Schapiro MB, Rapoport JL, Rapoport SI.

Psychiatry Res. 1991 Dec;40(4):221-37.

PMID:
1811240
14.

Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently.

Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, Huang SC, Wu HM, Au SC, Baxter LR Jr.

Biol Psychiatry. 2001 Aug 1;50(3):159-70.

PMID:
11513814
15.

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.

Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, Ho MK, Huang SC, Wu HM, Baxter LR Jr.

Arch Gen Psychiatry. 2002 Mar;59(3):250-61.

PMID:
11879163
16.

Bilateral orbitomedial leucotomy for obsessive-compulsive disorder: a single-case study using positron emission tomography.

Sachdev P, Trollor J, Walker A, Wen W, Fulham M, Smith JS, Matheson J.

Aust N Z J Psychiatry. 2001 Oct;35(5):684-90.

PMID:
11551286
17.

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder.

Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S, Phelps ME, Baxter LR Jr.

Neuropsychopharmacology. 1999 Dec;21(6):683-93.

18.

A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals.

Cottraux J, Gérard D, Cinotti L, Froment JC, Deiber MP, Le Bars D, Galy G, Millet P, Labbé C, Lavenne F, Bouvard M, Mauguière F.

Psychiatry Res. 1996 Mar 29;60(2-3):101-12.

PMID:
8723300
19.

Regional cerebral glucose metabolism of women with trichotillomania.

Swedo SE, Rapoport JL, Leonard HL, Schapiro MB, Rapoport SI, Grady CL.

Arch Gen Psychiatry. 1991 Sep;48(9):828-33.

PMID:
1929773
20.

Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.

Kim E, Howes OD, Park JW, Kim SN, Shin SA, Kim BH, Turkheimer FE, Lee YS, Kwon JS.

Psychol Med. 2016 Jan;46(2):357-66. doi: 10.1017/S0033291715001865. Epub 2015 Oct 1.

PMID:
26423910

Supplemental Content

Support Center